Upload data/gene_burden_matrix.json with huggingface_hub
Browse files- data/gene_burden_matrix.json +230 -0
data/gene_burden_matrix.json
ADDED
|
@@ -0,0 +1,230 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"title": "MVA Syndrome & Pediatric Oncology Candidate Gene Burden Matrix",
|
| 3 |
+
"description": "Multi-gene burden analysis across Spindle Assembly Checkpoint, Centrosome, Kinetochore, and Pediatric Cancer loci in Proband EX2312012.",
|
| 4 |
+
"genes": [
|
| 5 |
+
{
|
| 6 |
+
"gene": "BUB1B",
|
| 7 |
+
"omim": "MIM#257300",
|
| 8 |
+
"cytoband": "15q15.1",
|
| 9 |
+
"syndrome": "MVA Syndrome Type 1",
|
| 10 |
+
"complex": "Mitotic Checkpoint Complex (MCC)",
|
| 11 |
+
"role": "SAC Kinase / CDC20 Inhibitor",
|
| 12 |
+
"inheritance": "Autosomal Recessive / Compound Het",
|
| 13 |
+
"patient_variants": 63,
|
| 14 |
+
"highest_vaf": "53.8%",
|
| 15 |
+
"mosaic_candidates": 3,
|
| 16 |
+
"clinical_link": "Rhabdomyosarcoma, Wilms Tumour, Microcephaly, IUGR, Prematurity",
|
| 17 |
+
"pathogenicity_tier": "Tier 1: Primary Diagnostic Candidate"
|
| 18 |
+
},
|
| 19 |
+
{
|
| 20 |
+
"gene": "CEP57",
|
| 21 |
+
"omim": "MIM#614114",
|
| 22 |
+
"cytoband": "11q21",
|
| 23 |
+
"syndrome": "MVA Syndrome Type 2",
|
| 24 |
+
"complex": "Centrosomal Barrel Core",
|
| 25 |
+
"role": "Centrosome Scaffolding / Microtubule Nucleation",
|
| 26 |
+
"inheritance": "Autosomal Recessive",
|
| 27 |
+
"patient_variants": 10,
|
| 28 |
+
"highest_vaf": "50.0%",
|
| 29 |
+
"mosaic_candidates": 0,
|
| 30 |
+
"clinical_link": "Growth Restriction, Rhizomelia, Nephrocalcinosis, Microcephaly",
|
| 31 |
+
"pathogenicity_tier": "Tier 1: Primary Diagnostic Candidate"
|
| 32 |
+
},
|
| 33 |
+
{
|
| 34 |
+
"gene": "TRIP13",
|
| 35 |
+
"omim": "MIM#617598",
|
| 36 |
+
"cytoband": "5p15.33",
|
| 37 |
+
"syndrome": "MVA Syndrome Type 3",
|
| 38 |
+
"complex": "SAC Remodeler AAA+ ATPase",
|
| 39 |
+
"role": "Converts Closed-MAD2 (C-MAD2) to Open-MAD2 (O-MAD2)",
|
| 40 |
+
"inheritance": "Autosomal Recessive",
|
| 41 |
+
"patient_variants": 3,
|
| 42 |
+
"highest_vaf": "28.6% (Mosaic)",
|
| 43 |
+
"mosaic_candidates": 1,
|
| 44 |
+
"clinical_link": "Wilms Tumour, Rhabdomyosarcoma, Variegated Aneuploidy",
|
| 45 |
+
"pathogenicity_tier": "Tier 1: High-Confidence Mosaic Somatic Driver"
|
| 46 |
+
},
|
| 47 |
+
{
|
| 48 |
+
"gene": "CEP192",
|
| 49 |
+
"omim": "MIM#619934",
|
| 50 |
+
"cytoband": "18p11.21",
|
| 51 |
+
"syndrome": "MVA Syndrome Type 4",
|
| 52 |
+
"complex": "Pericentriolar Material (PCM)",
|
| 53 |
+
"role": "AURKA / PLK1 Mitotic Spindle Recruitment",
|
| 54 |
+
"inheritance": "Autosomal Recessive",
|
| 55 |
+
"patient_variants": 219,
|
| 56 |
+
"highest_vaf": "100.0%",
|
| 57 |
+
"mosaic_candidates": 14,
|
| 58 |
+
"clinical_link": "Short Stature, Microcephaly, Failure to Thrive, Aneuploidy",
|
| 59 |
+
"pathogenicity_tier": "Tier 1: High Burden Candidate"
|
| 60 |
+
},
|
| 61 |
+
{
|
| 62 |
+
"gene": "MAD1L1",
|
| 63 |
+
"omim": "MIM#602686",
|
| 64 |
+
"cytoband": "7p22.3",
|
| 65 |
+
"syndrome": "MVA Susceptibility / CIN",
|
| 66 |
+
"complex": "Kinetochore SAC Corona",
|
| 67 |
+
"role": "MAD2 Kinetochore Receptor & Dimerization",
|
| 68 |
+
"inheritance": "Autosomal Dominant / Recessive",
|
| 69 |
+
"patient_variants": 889,
|
| 70 |
+
"highest_vaf": "100.0%",
|
| 71 |
+
"mosaic_candidates": 51,
|
| 72 |
+
"clinical_link": "Mosaic Aneuploidy, Systemic Malignancies, Developmental Delay",
|
| 73 |
+
"pathogenicity_tier": "Tier 2: Major Kinetochore Burden"
|
| 74 |
+
},
|
| 75 |
+
{
|
| 76 |
+
"gene": "MAD2L1",
|
| 77 |
+
"omim": "MIM#601467",
|
| 78 |
+
"cytoband": "4q27",
|
| 79 |
+
"syndrome": "SAC Core Checkpoint",
|
| 80 |
+
"complex": "Mitotic Checkpoint Complex (MCC)",
|
| 81 |
+
"role": "Direct CDC20 Sequestration / Anaphase Clamp",
|
| 82 |
+
"inheritance": "Autosomal Dominant / Somatic",
|
| 83 |
+
"patient_variants": 14,
|
| 84 |
+
"highest_vaf": "52.4%",
|
| 85 |
+
"mosaic_candidates": 1,
|
| 86 |
+
"clinical_link": "Mitotic Arrest Deficiency, CIN, Tumorigenesis",
|
| 87 |
+
"pathogenicity_tier": "Tier 2: Core Checkpoint Regulator"
|
| 88 |
+
},
|
| 89 |
+
{
|
| 90 |
+
"gene": "BUB1",
|
| 91 |
+
"omim": "MIM#602452",
|
| 92 |
+
"cytoband": "2q13",
|
| 93 |
+
"syndrome": "Primary Microcephaly / CIN",
|
| 94 |
+
"complex": "Outer Kinetochore Kinase",
|
| 95 |
+
"role": "H2A Thr120 Phosphorylation / Shugoshin Recruitment",
|
| 96 |
+
"inheritance": "Autosomal Recessive",
|
| 97 |
+
"patient_variants": 15,
|
| 98 |
+
"highest_vaf": "100.0%",
|
| 99 |
+
"mosaic_candidates": 1,
|
| 100 |
+
"clinical_link": "Variegated Aneuploidy, Colorectal & Soft Tissue Tumours",
|
| 101 |
+
"pathogenicity_tier": "Tier 2: Centromeric Cohesion"
|
| 102 |
+
},
|
| 103 |
+
{
|
| 104 |
+
"gene": "BUB3",
|
| 105 |
+
"omim": "MIM#603424",
|
| 106 |
+
"cytoband": "10q26.13",
|
| 107 |
+
"syndrome": "SAC Scaffolding Component",
|
| 108 |
+
"complex": "Kinetochore WD40 Scaffold",
|
| 109 |
+
"role": "MELT Motif Recognition on KNL1",
|
| 110 |
+
"inheritance": "Autosomal Dominant / Somatic",
|
| 111 |
+
"patient_variants": 58,
|
| 112 |
+
"highest_vaf": "100.0%",
|
| 113 |
+
"mosaic_candidates": 2,
|
| 114 |
+
"clinical_link": "Chromosomal Nondisjunction, Embryonic Lethality",
|
| 115 |
+
"pathogenicity_tier": "Tier 2: Kinetochore Docking"
|
| 116 |
+
},
|
| 117 |
+
{
|
| 118 |
+
"gene": "SMC5",
|
| 119 |
+
"omim": "MIM#609313",
|
| 120 |
+
"cytoband": "9q21.11",
|
| 121 |
+
"syndrome": "Atelencephaly / Microcephaly",
|
| 122 |
+
"complex": "Structural Maintenance of Chromosomes",
|
| 123 |
+
"role": "Chromosome Condensation & Decatenation",
|
| 124 |
+
"inheritance": "Autosomal Recessive",
|
| 125 |
+
"patient_variants": 74,
|
| 126 |
+
"highest_vaf": "100.0%",
|
| 127 |
+
"mosaic_candidates": 4,
|
| 128 |
+
"clinical_link": "Chromosomal Instability, Growth Retardation, Facial Dysmorphism",
|
| 129 |
+
"pathogenicity_tier": "Tier 2: Cohesion & DNA Repair"
|
| 130 |
+
},
|
| 131 |
+
{
|
| 132 |
+
"gene": "CENPE",
|
| 133 |
+
"omim": "MIM#117143",
|
| 134 |
+
"cytoband": "4q24",
|
| 135 |
+
"syndrome": "Microcephalic Primordial Dwarfism",
|
| 136 |
+
"complex": "Outer Kinetochore Motor",
|
| 137 |
+
"role": "Kinesin-7 Plus-End Microtubule Translocase",
|
| 138 |
+
"inheritance": "Autosomal Recessive",
|
| 139 |
+
"patient_variants": 76,
|
| 140 |
+
"highest_vaf": "100.0%",
|
| 141 |
+
"mosaic_candidates": 3,
|
| 142 |
+
"clinical_link": "Severe IUGR, Microcephaly, Chromosome Misalignment",
|
| 143 |
+
"pathogenicity_tier": "Tier 2: Motor Translocation"
|
| 144 |
+
},
|
| 145 |
+
{
|
| 146 |
+
"gene": "CENPF",
|
| 147 |
+
"omim": "MIM#600236",
|
| 148 |
+
"cytoband": "1q41",
|
| 149 |
+
"syndrome": "Stromme Syndrome",
|
| 150 |
+
"complex": "Outer Kinetochore Corona",
|
| 151 |
+
"role": "Dynein / Kinetochore Maturation & Spindle Orientation",
|
| 152 |
+
"inheritance": "Autosomal Recessive",
|
| 153 |
+
"patient_variants": 74,
|
| 154 |
+
"highest_vaf": "100.0%",
|
| 155 |
+
"mosaic_candidates": 2,
|
| 156 |
+
"clinical_link": "Intrauterine Growth Restriction, Renal Hypoplasia, Microcephaly",
|
| 157 |
+
"pathogenicity_tier": "Tier 2: Ciliopathy & Kinetochore"
|
| 158 |
+
},
|
| 159 |
+
{
|
| 160 |
+
"gene": "PLK1",
|
| 161 |
+
"omim": "MIM#602098",
|
| 162 |
+
"cytoband": "16p12.2",
|
| 163 |
+
"syndrome": "Mitotic Master Kinase",
|
| 164 |
+
"complex": "Centrosome & Kinetochore Kinase",
|
| 165 |
+
"role": "Centrosome Maturation & Cohesin Release Trigger",
|
| 166 |
+
"inheritance": "Somatic / Oncogenic",
|
| 167 |
+
"patient_variants": 3,
|
| 168 |
+
"highest_vaf": "50.0%",
|
| 169 |
+
"mosaic_candidates": 0,
|
| 170 |
+
"clinical_link": "Rhabdomyosarcoma Oncogenesis, Mitotic Deregulation",
|
| 171 |
+
"pathogenicity_tier": "Tier 3: Mitotic Phospho-Regulator"
|
| 172 |
+
},
|
| 173 |
+
{
|
| 174 |
+
"gene": "AURKA",
|
| 175 |
+
"omim": "MIM#603072",
|
| 176 |
+
"cytoband": "20q13.2",
|
| 177 |
+
"syndrome": "Aurora Kinase A",
|
| 178 |
+
"complex": "Centrosomal Spindle Pole Kinase",
|
| 179 |
+
"role": "Bipolar Spindle Assembly & Centrosome Separation",
|
| 180 |
+
"inheritance": "Somatic / Oncogenic",
|
| 181 |
+
"patient_variants": 16,
|
| 182 |
+
"highest_vaf": "100.0%",
|
| 183 |
+
"mosaic_candidates": 1,
|
| 184 |
+
"clinical_link": "Aneuploidy Induction, Centrosome Amplification, Sarcoma",
|
| 185 |
+
"pathogenicity_tier": "Tier 3: Spindle Pole Kinase"
|
| 186 |
+
},
|
| 187 |
+
{
|
| 188 |
+
"gene": "TP53",
|
| 189 |
+
"omim": "MIM#191170",
|
| 190 |
+
"cytoband": "17p13.1",
|
| 191 |
+
"syndrome": "Li-Fraumeni Syndrome",
|
| 192 |
+
"complex": "Tumor Suppressor Guardian",
|
| 193 |
+
"role": "Tetrameric DNA Damage & Aneuploidy Checkpoint",
|
| 194 |
+
"inheritance": "Autosomal Dominant / Somatic",
|
| 195 |
+
"patient_variants": 16,
|
| 196 |
+
"highest_vaf": "100.0%",
|
| 197 |
+
"mosaic_candidates": 1,
|
| 198 |
+
"clinical_link": "Embryonal Rhabdomyosarcoma, Soft Tissue Sarcomas, Adrenocortical Tumours",
|
| 199 |
+
"pathogenicity_tier": "Tier 3: Sarcoma Driver Candidate"
|
| 200 |
+
},
|
| 201 |
+
{
|
| 202 |
+
"gene": "WT1",
|
| 203 |
+
"omim": "MIM#607102",
|
| 204 |
+
"cytoband": "11p13",
|
| 205 |
+
"syndrome": "Denys-Drash / WAGR Syndrome",
|
| 206 |
+
"complex": "Zinc-Finger Transcription Factor",
|
| 207 |
+
"role": "Nephrogenesis & Mesenchymal-Epithelial Transition",
|
| 208 |
+
"inheritance": "Autosomal Dominant / Recessive",
|
| 209 |
+
"patient_variants": 19,
|
| 210 |
+
"highest_vaf": "100.0%",
|
| 211 |
+
"mosaic_candidates": 0,
|
| 212 |
+
"clinical_link": "Congenital Nephrocalcinosis, Wilms Tumour, Genitourinary Defects",
|
| 213 |
+
"pathogenicity_tier": "Tier 3: Renal Phenotype Corroboration"
|
| 214 |
+
},
|
| 215 |
+
{
|
| 216 |
+
"gene": "DICER1",
|
| 217 |
+
"omim": "MIM#606241",
|
| 218 |
+
"cytoband": "14q32.13",
|
| 219 |
+
"syndrome": "DICER1 Tumour Predisposition",
|
| 220 |
+
"complex": "miRNA Processing Endoribonuclease",
|
| 221 |
+
"role": "MicroRNA Biogenesis & Heterochromatin Maintenance",
|
| 222 |
+
"inheritance": "Autosomal Dominant",
|
| 223 |
+
"patient_variants": 27,
|
| 224 |
+
"highest_vaf": "100.0%",
|
| 225 |
+
"mosaic_candidates": 1,
|
| 226 |
+
"clinical_link": "Embryonal Rhabdomyosarcoma, Pleuropulmonary Blastoma, Cystic Nephroma",
|
| 227 |
+
"pathogenicity_tier": "Tier 3: Pediatric Oncology Predisposition"
|
| 228 |
+
}
|
| 229 |
+
]
|
| 230 |
+
}
|